PROVIDER PROFILE · NPI 1922276781

Dahlia LandaMD

Allergy/ ImmunologyBronx, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

228

Unique beneficiaries

—

Total services

4,278

Distinct HCPCS

Medicare payment

$31K

Peer benchmark

Total Medicare services vs. 272 Allergy/ Immunology providers in NY — above median (cohort median 2,067).

PRESCRIBING · PART D · 2024

Total Rx claims

611

Beneficiaries

—

Total drug cost

$478K

Distinct drugs

Brand share

24.2%

Top prescribed drugs

Epinephrine145 claims

Azelastine Hcl138 claims

Dupilumab97 claims

Fluticasone Propionate96 claims

Montelukast Sodium53 claims

QUALITY · MIPS · 2024

Final MIPS score

94.5

Quality

89.9

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.82%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Food and Beverage$1K

Education$58

REFERRAL NETWORK

Where Dahlia Landa's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Javid Nassiri Otolaryngology · Valley Stream, NY	26	83
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Melville, NY	11	86

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history